Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2015 | 25.31 Million USD | 28.42% |
| 2014 | 19.71 Million USD | 14.03% |
| 2013 | 17.29 Million USD | 8.22% |
| 2012 | 15.97 Million USD | -3.69% |
| 2011 | 16.59 Million USD | 5.69% |
| 2010 | 15.69 Million USD | 23.09% |
| 2009 | 12.75 Million USD | 2.05% |
| 2008 | 12.49 Million USD | 35.22% |
| 2007 | 9.24 Million USD | 77.88% |
| 2006 | 5.19 Million USD | 60.08% |
| 2005 | 3.24 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2015 FY | 25.31 Million USD | 28.42% |
| 2015 Q1 | 5.11 Million USD | 8.81% |
| 2014 Q2 | 4.8 Million USD | -2.66% |
| 2014 Q3 | 5.27 Million USD | 9.86% |
| 2014 Q4 | 4.7 Million USD | -10.89% |
| 2014 Q1 | 4.93 Million USD | -9.44% |
| 2014 FY | 19.71 Million USD | 14.03% |
| 2013 Q1 | 3.87 Million USD | 11.79% |
| 2013 Q4 | 5.44 Million USD | 33.25% |
| 2013 Q2 | 3.87 Million USD | 0.11% |
| 2013 Q3 | 4.08 Million USD | 5.43% |
| 2013 FY | 17.29 Million USD | 8.22% |
| 2012 FY | 15.97 Million USD | -3.69% |
| 2012 Q4 | 3.46 Million USD | -13.98% |
| 2012 Q3 | 4.02 Million USD | -2.09% |
| 2012 Q2 | 4.11 Million USD | -6.08% |
| 2012 Q1 | 4.38 Million USD | -14.93% |
| 2011 Q2 | 3.98 Million USD | 14.52% |
| 2011 Q4 | 5.15 Million USD | 29.69% |
| 2011 FY | 16.59 Million USD | 5.69% |
| 2011 Q1 | 3.48 Million USD | -24.41% |
| 2011 Q3 | 3.97 Million USD | -0.35% |
| 2010 Q4 | 4.6 Million USD | 18.22% |
| 2010 Q2 | 3.54 Million USD | -2.86% |
| 2010 Q1 | 3.65 Million USD | 18.84% |
| 2010 FY | 15.69 Million USD | 23.09% |
| 2010 Q3 | 3.89 Million USD | 9.84% |
| 2009 FY | 12.75 Million USD | 2.05% |
| 2009 Q1 | 3.62 Million USD | 11.14% |
| 2009 Q4 | 3.07 Million USD | 0.57% |
| 2009 Q2 | 3 Million USD | -16.99% |
| 2009 Q3 | 3.05 Million USD | 1.64% |
| 2008 Q3 | 2.03 Million USD | -35.74% |
| 2008 Q1 | 2.87 Million USD | 20.49% |
| 2008 FY | 12.49 Million USD | 35.22% |
| 2008 Q4 | 3.25 Million USD | 60.38% |
| 2008 Q2 | 3.16 Million USD | 9.88% |
| 2007 FY | 9.24 Million USD | 77.88% |
| 2007 Q4 | 2.38 Million USD | -1.71% |
| 2007 Q3 | 2.42 Million USD | -14.51% |
| 2007 Q2 | 2.84 Million USD | 79.45% |
| 2007 Q1 | 1.58 Million USD | -24.54% |
| 2006 Q4 | 2.09 Million USD | 68.61% |
| 2006 FY | 5.19 Million USD | 60.08% |
| 2006 Q3 | 1.24 Million USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 FY | 3.24 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -2313.632% |
| Arrayit Corporation | 6.19 Million USD | -308.531% |
| Atlantic International Corp. | 5.57 Million USD | -353.886% |
| Biocept, Inc. | 29.4 Million USD | 13.884% |
| Bioqual, Inc. | 7.44 Million USD | -239.908% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -3179.06% |
| DermTech, Inc. | 104.01 Million USD | 75.658% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 84.794% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -11.914% |
| iMD Companies, Inc. | 151.8 Thousand USD | -16578.194% |
| IDenta Corp. | 662.97 Thousand USD | -3718.998% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -25.143% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -65019.21% |
| InVitro International | 661.32 Thousand USD | -3728.532% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -256.706% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -43469.314% |
| Medical Imaging Corp. | 1.91 Million USD | -1224.102% |
| NovelStem International Corp. | 3.53 Million USD | -615.671% |
| Optigenex Inc. | 1.28 Million USD | -1865.961% |
| PharmChem, Inc. | 2.93 Million USD | -763.767% |
| Proteome Sciences plc | 3.26 Million USD | -674.755% |
| Rennova Health, Inc. | 7.67 Million USD | -229.77% |
| RushNet, Inc. | 1.78 Million USD | -1315.007% |
| ScreenPro Security Inc. | 3.23 Million USD | -681.713% |
| Stella Diagnostics Inc. | 11.42 Million USD | -121.573% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -244.804% |
| Todos Medical Ltd. | 14.05 Million USD | -80.104% |